{"id":294211,"date":"2026-10-08T11:12:50","date_gmt":"2026-10-08T05:42:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=294211"},"modified":"2026-10-08T11:12:50","modified_gmt":"2026-10-08T05:42:50","slug":"alkem-labs-vs-biocon-vs-glenmark-pharma","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/","title":{"rendered":"Alkem Labs vs Biocon vs Glenmark Pharma: Which Stock Should You Track"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Alkem Laboratories PE 28.95, mkt cap Rs 63,814 crore. Biocon PE 153.96, mkt cap Rs 64,234 crore. Glenmark Pharmaceuticals PE 37.41, mkt cap Rs 67,254 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals is a side-by-side comparison of three companies from the Pharma and Biotech space. On this comparison, Alkem Laboratories carries a market capitalisation of about Rs 63,814 crore against Rs 64,234 crore for Biocon and Rs 67,254 crore for Glenmark Pharmaceuticals, with return on equity of 16.66%, 1.14% and 28.08% respectively. Each company&#8217;s numbers are presented here without a declared better pick, since the right stock depends on an investor&#8217;s own criteria.<\/p>\n<\/div>\n<p>Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals starts with the core numbers most investors compare within the Pharma and Biotech segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of October 2026 and will shift with daily price moves.<\/p>\n<p>All three names sit in the Pharma and Biotech bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=alkem-labs-vs-biocon-vs-glenmark-pharma\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Alkem_Laboratories_Biocon_and_Glenmark_Pharmaceuticals_Company_Overview\" title=\"Alkem Laboratories, Biocon and Glenmark Pharmaceuticals: Company Overview\">Alkem Laboratories, Biocon and Glenmark Pharmaceuticals: Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Alkem_Laboratories_vs_Biocon_vs_Glenmark_Pharmaceuticals_Valuation_and_Profitability_Snapshot\" title=\"Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals: Valuation and Profitability Snapshot\">Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals: Valuation and Profitability Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Alkem_Laboratories_vs_Biocon_vs_Glenmark_Pharmaceuticals_Latest_Quarterly_Results\" title=\"Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals: Latest Quarterly Results\">Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals: Latest Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#What_Should_Investors_Look_at_Beyond_These_Numbers\" title=\"What Should Investors Look at Beyond These Numbers?\">What Should Investors Look at Beyond These Numbers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#FAQs_on_Alkem_Laboratories_vs_Biocon_vs_Glenmark_Pharmaceuticals\" title=\"FAQs on Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals\">FAQs on Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#What_is_the_market_cap_difference_between_Alkem_Laboratories_Biocon_and_Glenmark_Pharmaceuticals\" title=\"What is the market cap difference between Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?\">What is the market cap difference between Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Which_of_the_three_has_the_highest_PE_ratio\" title=\"Which of the three has the highest PE ratio?\">Which of the three has the highest PE ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Which_of_the_three_has_the_highest_ROE\" title=\"Which of the three has the highest ROE?\">Which of the three has the highest ROE?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Which_of_these_three_stocks_pays_the_highest_dividend_yield\" title=\"Which of these three stocks pays the highest dividend yield?\">Which of these three stocks pays the highest dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#What_is_the_debt_to_equity_ratio_for_Alkem_Laboratories_Biocon_and_Glenmark_Pharmaceuticals\" title=\"What is the debt to equity ratio for Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?\">What is the debt to equity ratio for Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Which_of_the_three_trades_at_the_highest_price_to_book_value\" title=\"Which of the three trades at the highest price to book value?\">Which of the three trades at the highest price to book value?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/alkem-labs-vs-biocon-vs-glenmark-pharma\/#Is_one_of_Alkem_Laboratories_Biocon_or_Glenmark_Pharmaceuticals_better_than_the_others\" title=\"Is one of Alkem Laboratories, Biocon or Glenmark Pharmaceuticals better than the others?\">Is one of Alkem Laboratories, Biocon or Glenmark Pharmaceuticals better than the others?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Biocon_and_Glenmark_Pharmaceuticals_Company_Overview\"><\/span><strong>Alkem Laboratories, Biocon and Glenmark Pharmaceuticals: Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Alkem Laboratories<\/strong> is a listed Indian company in the Pharma and Biotech space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.<\/p>\n<p><strong>Biocon<\/strong> is a listed Indian company in the Pharma and Biotech space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.<\/p>\n<p><strong>Glenmark Pharmaceuticals<\/strong> is a listed Indian company in the Pharma and Biotech space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_vs_Biocon_vs_Glenmark_Pharmaceuticals_Valuation_and_Profitability_Snapshot\"><\/span><strong>Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals: Valuation and Profitability Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\">Biocon<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals<\/a><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Market Cap (approx.)<\/td>\n<td>Rs 63,814 crore<\/td>\n<td>Rs 64,234 crore<\/td>\n<td>Rs 67,254 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio (TTM)<\/td>\n<td>28.95<\/td>\n<td>153.96<\/td>\n<td>37.41<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>4.62<\/td>\n<td>1.86<\/td>\n<td>6.40<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity (ROE)<\/td>\n<td>16.66%<\/td>\n<td>1.14%<\/td>\n<td>28.08%<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM, Rs)<\/td>\n<td>184.35<\/td>\n<td>2.56<\/td>\n<td>63.70<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>0.99%<\/td>\n<td>0.13%<\/td>\n<td>0.21%<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.15<\/td>\n<td>0.45<\/td>\n<td>0.06<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share (Rs)<\/td>\n<td>1155.87<\/td>\n<td>211.51<\/td>\n<td>372.47<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Data<\/strong><\/a><\/p>\n<p>On valuation, Alkem Laboratories trades at a PE of 28.95 and a PB of 4.62, Biocon at a PE of 153.96 and a PB of 1.86, while Glenmark Pharmaceuticals trades at a PE of 37.41 and a PB of 6.40. On return on equity, the three post 16.66%, 1.14% and 28.08% respectively, and on dividend yield they stand at 0.99%, 0.13% and 0.21%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_vs_Biocon_vs_Glenmark_Pharmaceuticals_Latest_Quarterly_Results\"><\/span><strong>Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals: Latest Quarterly Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Latest Quarter Revenue<\/th>\n<th>Latest Quarter Net Profit<\/th>\n<th>YoY Change (Revenue)<\/th>\n<th>QoQ Change (Revenue)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Alkem Laboratories<\/td>\n<td>Rs 3,892.90 crore<\/td>\n<td>Rs 521.49 crore<\/td>\n<td>+11.0%<\/td>\n<td>+2.4%<\/td>\n<\/tr>\n<tr>\n<td>Biocon<\/td>\n<td>Rs 4,390.50 crore<\/td>\n<td>Rs 136.80 crore<\/td>\n<td>+9.2%<\/td>\n<td>-3.9%<\/td>\n<\/tr>\n<tr>\n<td>Glenmark Pharmaceuticals<\/td>\n<td>Rs 4,084.24 crore<\/td>\n<td>Rs 482.83 crore<\/td>\n<td>+24.1%<\/td>\n<td>+3.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Alkem Laboratories, Biocon and Glenmark Pharmaceuticals live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Look_at_Beyond_These_Numbers\"><\/span><strong>What Should Investors Look at Beyond These Numbers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Beyond the metrics above, investors comparing these three pharma and biotech names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals highlights how differently three companies in the same pharma and biotech segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information as of October 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Alkem_Laboratories_vs_Biocon_vs_Glenmark_Pharmaceuticals\"><\/span><strong>FAQs on Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_difference_between_Alkem_Laboratories_Biocon_and_Glenmark_Pharmaceuticals\"><\/span><strong>What is the market cap difference between Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of October 2026, Alkem Laboratories has a market cap of approximately Rs 63,814 crore, Biocon is at approximately Rs 64,234 crore, and Glenmark Pharmaceuticals is at approximately Rs 67,254 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_the_three_has_the_highest_PE_ratio\"><\/span><strong>Which of the three has the highest PE ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Among Alkem Laboratories, Biocon and Glenmark Pharmaceuticals, the PE ratios stand at 28.95, 153.96 and 37.41 respectively as of October 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_the_three_has_the_highest_ROE\"><\/span><strong>Which of the three has the highest ROE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories, Biocon and Glenmark Pharmaceuticals post ROE of 16.66%, 1.14% and 28.08% respectively as of October 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_three_stocks_pays_the_highest_dividend_yield\"><\/span><strong>Which of these three stocks pays the highest dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories, Biocon and Glenmark Pharmaceuticals carry dividend yields of 0.99%, 0.13% and 0.21% respectively.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_debt_to_equity_ratio_for_Alkem_Laboratories_Biocon_and_Glenmark_Pharmaceuticals\"><\/span><strong>What is the debt to equity ratio for Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories carries a debt to equity of 0.15, Biocon of 0.45, and Glenmark Pharmaceuticals of 0.06.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_the_three_trades_at_the_highest_price_to_book_value\"><\/span><strong>Which of the three trades at the highest price to book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories, Biocon and Glenmark Pharmaceuticals trade at price to book ratios of 4.62, 1.86 and 6.40 respectively.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_one_of_Alkem_Laboratories_Biocon_or_Glenmark_Pharmaceuticals_better_than_the_others\"><\/span><strong>Is one of Alkem Laboratories, Biocon or Glenmark Pharmaceuticals better than the others?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor&#8217;s own criteria and research.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the market cap difference between Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of October 2026, Alkem Laboratories has a market cap of approximately Rs 63,814 crore, Biocon is at approximately Rs 64,234 crore, and Glenmark Pharmaceuticals is at approximately Rs 67,254 crore.\"}},{\"@type\":\"Question\",\"name\":\"Which of the three has the highest PE ratio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Among Alkem Laboratories, Biocon and Glenmark Pharmaceuticals, the PE ratios stand at 28.95, 153.96 and 37.41 respectively as of October 2026.\"}},{\"@type\":\"Question\",\"name\":\"Which of the three has the highest ROE?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alkem Laboratories, Biocon and Glenmark Pharmaceuticals post ROE of 16.66%, 1.14% and 28.08% respectively as of October 2026.\"}},{\"@type\":\"Question\",\"name\":\"Which of these three stocks pays the highest dividend yield?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alkem Laboratories, Biocon and Glenmark Pharmaceuticals carry dividend yields of 0.99%, 0.13% and 0.21% respectively.\"}},{\"@type\":\"Question\",\"name\":\"What is the debt to equity ratio for Alkem Laboratories, Biocon and Glenmark Pharmaceuticals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alkem Laboratories carries a debt to equity of 0.15, Biocon of 0.45, and Glenmark Pharmaceuticals of 0.06.\"}},{\"@type\":\"Question\",\"name\":\"Which of the three trades at the highest price to book value?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Alkem Laboratories, Biocon and Glenmark Pharmaceuticals trade at price to book ratios of 4.62, 1.86 and 6.40 respectively.\"}},{\"@type\":\"Question\",\"name\":\"Is one of Alkem Laboratories, Biocon or Glenmark Pharmaceuticals better than the others?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of October 2026.<\/p>\n","protected":false},"author":36,"featured_media":294210,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[10016,1019],"class_list":["post-294211","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-pharma-and-biotech","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["294210"],"rank_math_title":["Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals"],"rank_math_description":["Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of October 2026."],"rank_math_focus_keyword":["Alkem Laboratories vs Biocon vs Glenmark Pharmaceuticals"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/alkem-labs-vs-biocon-vs-glenmark-pharma-which-stock-should-you-track.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/294211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=294211"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/294211\/revisions"}],"predecessor-version":[{"id":294212,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/294211\/revisions\/294212"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/294210"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=294211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=294211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=294211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}